| Page No 1 2 3 4 |
| Phrase | Consultant | Town | Special Interests |
| clinical risk management | *Consultant(s)* | *Towns* | Labour ward management, pelvic surgery, feto-maternal medicine, minimal access surgery, vaginal surgery, high risk obstetrics, benign gynaecology, clinical risk management |
| Clinical risk management | *Consultant(s)* | *Towns* | Clinical risk management, teaching, medical law |
| clinical service development | *Consultant(s)* | *Towns* | Neurointensive care, strategic planning for healthcare, health system integration, clinical service development |
| clinical trial design and reporting | *Consultant(s)* | *Towns* | Interventional cardiology, stenting, angioplasty, clinical trial design and reporting, alcohol ablation in hypertrophic obstructive cardiomyopathy, transcatheter aortic valve implantation - TAVI |
| core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| development of early phase clinical trials of anti-cancer therapies | *Consultant(s)* | *Towns* | Medical oncology, development of early phase clinical trials of anti-cancer therapies |
| Early phase clinical trials | *Consultant(s)* | *Towns* | Early phase clinical trials, the role of the p53/MDM2 pathway in radioresistance and cellular motility, the therapeutic exploitation of the unfolded protein response in head and neck cancer, treatment response in HPV - human papilloma virus +ve oropharyngeal cancer intraoperative radiotherapy, core and swallowing outcomes in late phase clinical trials involving patients with OPSCC - oropharyngeal squamous cell carcinoma, function sparing surgical strategies for head and neck cancer - especially transoral laser microsurgery |
| early phase clinical trials | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, early phase clinical trials, immunotherapy |
| Expert in clinical negligence | *Consultant(s)* | *Towns* | Expert in clinical negligence |
| general clinical biochemistry | *Consultant(s)* | *Towns* | Lipids and cardiovascular risk management, specialist obesity management, general clinical biochemistry, diabetes, medical education |
| medical director clinical and scientific services | *Consultant(s)* | *Towns* | Gastrointestinal imaging, nonvascular interventional radiology, radiology of weight reduction therapies including gastric band adjustment, medical director clinical and scientific services |
| Page No 1 2 3 4 |
